A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LVSI / lymphovascular space involvement

[Related PubMed/MEDLINE]
Total Number of Papers: 90
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LVSI  (>> Co-occurring Abbreviation)
Long Form:   lymphovascular space involvement
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes. HR
2019 Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy. LNR, SCC-Ag
2018 Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis. DFS, DSI, FIGO, LNM, OS, PI, RT, SCNEC
2018 Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery? ---
2018 Vulvar cancer recurrence - an analysis of prognostic factors in tumour-free pathological margins patients group. ---
2018 [Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis]. CK, EEC, MELF
2017 Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group. CI, EC, ESGO, ESMO, ESTRO, HIR, LN, SLNB
2017 Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer. DW-MRI, EC, FDG, MI, NPV, PET/CT
2017 Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma. DTC, MELF
10  2017 Micro-RNA signature of lymphovascular space involvement in type 1 endometrial cancer. EC
11  2016 Concomitant chemoradiation treatment in selected Stage I endometrioid endometrial cancers. CR, DFI, EC, RT, TD
12  2016 DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer. DLL4, FIGO, PLNM
13  2016 Prognostic impact of primary tumor SUVmax on preoperative 18F-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography in endometrial cancer and uterine carcinosarcoma. FDG, LN, OS, PET/CT, PFS
14  2016 Risk factors of node metastasis in cervical carcinoma. ---
15  2016 The Impact of Lymphovascular Space Invasion on Recurrence and Survival in Iranian Patients With Early Stage Endometrial Cancer. EC, FIGO
16  2016 [Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ⅰ b2 and Ⅱa2 cervical cancer: a prospective randomized control study]. CTCAE, NACT, OS, PII, RH
17  2016 [Metastatic mechanisms of uterine malignancies and therapeutic consequences]. ---
18  2015 Clinical implications of human leukocyte antigen class I expression in endometrial cancer. HLA, OS, PFS
19  2015 Clitoral involvement of squamous cell carcinoma of the vulva: localization with the worst prognosis. DSS, SCC
20  2015 Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer. AUCs, MTV, TLG
21  2015 Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study. OS, SCCC
22  2015 Review of neoadjuvant chemotherapy and trachelectomy: which cervical cancer patients would be suitable for neoadjuvant chemotherapy followed by fertility-sparing surgery? ART, NAC, VRT
23  2015 Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging. DCE, NPV, PPV, PTE, SEE
24  2015 The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma. LNM, LNs
25  2015 The potential for less radical surgery in women with stage IA2-IB1 cervical cancer. LNM, PI, UII
26  2014 Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China. MIC, OR
27  2014 Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study. DSI, ROC
28  2014 Maspin expression in endometrial hyperplasia and carcinoma, and its relation with angiogenesis. IHC, MI, OS, VEGF
29  2014 The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer. ---
30  2014 The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer. BMI, DFS, HR
31  2014 Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study. DFS, DOI, TFD
32  2013 Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy: should "staging" conization be systematically performed before this procedure? VRT
33  2013 Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. OS
34  2013 Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. EC, ER, ESMO, LNM, PR
35  2013 Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. EC
36  2013 Patient-tailored conservative surgical treatment of invasive uterine cervical squamous cell carcinoma. A review. SCC, SLN
37  2013 The effect of coexisting uterine myomas on clinico-pathological variables of endometrial carcinoma. EC
38  2013 The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma. AA, DSS, NAA, OS, RFS
39  2012 Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. AP, CSI, HRs, PPN, WAI
40  2012 Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer. ALN, DFS, ER, HER2, OS, PCNA, PR
41  2012 Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. EEA, PLN
42  2012 Colposcopy and management of microinvasive squamous cell carcinoma. DI, MIC
43  2012 Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement? RA-RH
44  2012 Management of microinvasive cervical cancer: a British Society for Colposcopy and Cervical Pathology audit. ---
45  2012 Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS. AUC, LOO, LSSVM, MS, SELDI-TOF
46  2012 The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. DSS, IRB, OS, RFS, RT
47  2012 Validity of laparoscopic staging to avoid adjuvant chemoradiation following radical surgery in patients with early cervical cancer. ---
48  2012 [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma]. DFS, OS, RR
49  2011 Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature. AC
50  2011 Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. RT
51  2011 Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement. NACT, NACT group
52  2011 Patterns of failures in endometrial cancer: clinicopathological variables predictive of the risk of local, distant and retroperitoneal failure. ---
53  2011 Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. ---
54  2010 Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literature. CIN
55  2009 Laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our instruments and technique. ---
56  2009 Liquid-based preparation for endometrial cytology--usefulness for predicting the prognosis of endometrial carcinoma preoperatively. ERalpha, LBC, MI, PRB
57  2009 Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer. ---
58  2009 Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. ---
59  2009 Prognostic impact of satellite-lymphovascular space involvement in early-stage cervical cancer. DFS, OAS
60  2009 Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. DOI, LUS, TFD
61  2008 Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. DSI, RFS and DSS, RH, RT
62  2007 Curative treatment of a pelvic side wall recurrence after conization for microinvasive cervical cancer stage IA1: a case report and review of the literature. LNM
63  2007 Early stage cervical cancer: adjuvant treatment in negative lymph node cases. DFS, SI
64  2007 Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. ---
65  2007 Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy. DFS, DI, LNM, TS
66  2006 Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. CI, HR
67  2006 Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis. ADC, ASC, FIGO, SCC
68  2006 Prognostic factors and survival of stage IB-IIA cervical cancer. DCSI, PLNM
69  2006 Statistical analysis of pathologic risk factors for intramyometrial lymphvascular space involvement in myoinvasive endometrial carcinoma. MI
70  2005 Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. LNMM
71  2005 Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. ---
72  2005 Prognostic factors in microinvasive cervical squamous cell cancer: long-term results. DI
73  2004 A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. ---
74  2004 A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? DFS, DOI, EBL, PI, RH
75  2004 Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. FIGO
76  2004 Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? ---
77  2004 Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. DI, LNM, RFS, TS
78  2004 Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. ---
79  2004 Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply? CSI, DFS, HR, IR, LR, PRT
80  2003 Microvessel density (MVD) as a prognosticator in endometrial carcinoma. EC, MVD
81  2003 Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins. CIN
82  2002 Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis. CEA, DSI, PLNM, RAH-PLND, SCC-Ag, TPA
83  2002 Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. LI
84  2001 Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. ---
85  2001 [Histopathological prognostic factors in primary surgically treated cervix carcinoma]. PLM
86  2000 Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. FIGO, RR, VIN
87  1998 Prognostic factors in surgically treated stage IB-IIB carcinoma of the cervix with negative lymph nodes. ---
88  1996 Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. DFS, DI, LNM, MIC
89  1996 Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. DFS, DI, LNM, TS, TV
90  1994 Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. ---